Tuesday, April 30, 2013

H4B Chelsea, Member Of Havas' Health4Brands Global Network, Named Agency of the Year

H4B Chelsea, Member Of Havas' Health4Brands Global Network, Named Agency of the Year

NEW YORK, April 30, 2013 /PRNewswire/ -- H4B Chelsea, an award-winning full-service, fully unified healthcare communications agency, has secured a major coup with the Category I Agency of the Year title from Med Ad News. Criteria considered for the award includes ability to attract talent, account wins, creative track record, financial performance, management strength and strategic thinking. H4B Chelsea—just three years old and the first agency established in Havas' global network Health4Brands—proved its mettle in each of those categories, with its third year of double-digit growth, a pitch win rate of 65 percent, a substantially expanded client roster, an innovative unified business model, an amazing staff retention rate and a sharp uptick of award-winning creative. 

In 2012, H4B Chelsea launched its "Always Fearless" agency campaign, a highlight of the way the agency is defining its vision and bringing it to life. In the past year alone, the agency has won more than 30 creative awards and 14 new AOR accounts. The group has more than tripled in size since its 2009 launch, and boasts an impressive 90 percent retention rate for its talented staff.

"To win this prestigious award from Med Ad News after just three years of operation is incredibly exciting, and it confirms what we already know—that we're producing best-in-class work and stellar results for our clients," said Christian Bauman , managing director, H4B Chelsea.

"We're proud to represent the flourishing global network Health4Brands, which is a unique worldwide force in that it fosters an entrepreneurial spirit in all the places it has a presence—and that has allowed us to achieve such great things in such a short time," added Steve Nothel , managing director.

The third member of H4B's management group, Michael Peto , managing director, elaborated, "Our group is 'Always Fearless,' a credo by which we work, and one that has made all the difference—we offer optimism and energy no matter what we're up against, and it's quite evident in our results."

About H4B Chelsea
A full-service, fully unified healthcare communications agency, H4B Chelsea is the New York hub of the global Health4Brands network, one of the world's leading healthcare communications companies. The 250-person agency sits inside of Chelsea Market (which is also the N.Y. home of Google, Food Network, and MLB.com), an old Nabisco factory, where the Oreo was born. Regardless of its cool location, H4B Chelsea is boundaryless—a full-service global communications company designed to ensure consistent messaging, maximization of resources, and speed to market for its clients' brands. For more information about H4B Chelsea, visit the company's website at
h4bchelsea.com.

Press Contact:
Terese Kelly
Havas PR North America
terese.kelly@havasww.com
646-715-9210

SOURCE H4B Chelsea

RELATED LINKS
http://www.h4bchelsea.com


Source: www.prnewswire.com

Monday, April 29, 2013

Red Bank New Jersey Dentist Dr. Sherrod Jewell Launches New Website

Red Bank New Jersey Dentist Dr. Sherrod Jewell Launches New Website

RED BANK, N.J., April 29, 2013 /PRNewswire/ -- Red Bank, NJ Dentist Dr. Carole Sherrod Jewell is announcing the launch of her new Red Bank Dentistry website at http://www.redbankdentistry.com. The new website provides people who are searching for a dentist in Red Bank New Jersey with information about the available dental services and insightful dental advice. "I'm pleased to launch our new website to show patients how we can help them improve their smiles, and read reviews from other satisfied patients." said Dr. Sherrod Jewell .

Thanks to new and innovative websites like Dr. Jewell's Red Bank Dentistry website, consumers can now get information about available dental procedures as well as dental office staff from the comfort of their own home. Whether a person is in need of preventive, cosmetic or restorative dentistry, Dr. Sherrod Jewell provides the dental treatments that achieve the results her patients want.

Dr. Sherrod Jewell provides the following dental services to the Red Bank, NJ area:

General & Preventive Dentistry

  • Checkups & Teeth Cleaning
  • Gum Disease Treatment
  • Sleep Apnea & Snoring Treatment
  • TMJ Treatment

Cosmetic Dentistry

  • Porcelain Veneers & Lumineers
  • Safe, Mercury-Free White Tooth Fillings
  • Teeth Whitening

Restorative Dentistry

  • Dental Implants
  • Dentures
  • Porcelain Tooth Crowns & Dental Bridges

Orthodontics & Braces

  • Invisalign Braces
  • Traditional Braces
  • Invisible short-term Braces

For more information about the cosmetic dentistry services offered by Dr. Sherrod Jewell or to schedule your free consultation, see:

http://www.redbankdentistry.com

About Dr. Carole Sherrod Jewell , DMD

Dr. Carole Sherrod Jewell , DMD is a Red Bank dentist providing general dentistry, cosmetic dentistry, reconstructive restorative dentistry and orthodontics.

Dr. Carole Sherrod Jewell has been helping people maintain healthy teeth and gums and providing beautiful smiles for almost 50 years. She began her dental career at the age of 13 as a young girl working for the neighborhood dentist in Red Bank, New Jersey. At 20 she became a registered dental hygienist. She enjoyed helping her patients so much that after 14 years she decided to go back to dental school and become a dentist. She graduated from the University of Medicine and Dentistry of New Jersey in 1987 and this year celebrated her 20th anniversary in the very building where she began her career.

Call (732) 741-4700 to schedule your dental appointment or free consultation or visit Dr. Sherrod Jewell online at http://www.RedBankDentistry.com

SOURCE Dr. Jewell

RELATED LINKS
http://www.RedBankDentistry.com


Source: www.prnewswire.com

Bladder Imaging Studies

Bladder Imaging Studies

Diagnosis of urinary incontinence will sometimes require imaging studies that give a physician a much better look at the structure and function of the different physiological parts of the urinary tract system. These parts include the kidneys, ureters, bladder and urethra. Each of these different parts plays a key role in helping the body to eliminate waste products from the blood. The kidneys filter the vascular system and eliminate waste products, concentrating them and sending them down the ureters for storage in the bladder before they are eventually expelled through the urethra.

Individuals who suffer from urinary incontinence can experience problems in several different arenas all of which cause urinary incontinence. These problems can be related to stress incontinence, overactive bladder, neurogenic bladders for overflow incontinence. In each of these cases imaging studies can assist the physician to confirm a diagnosis and outline a specific treatment protocol which should be more successful because the diagnosis was conclusive.

One of the more basic imaging studies are abdominal x-rays that are done without contrast material. In this particular x-ray done with contrast can tell highlight the kidneys and urinary collecting system which is of particular importance in specific types of structural abnormalities.

In instances when the physician is particularly interested in viewing the vascular structures that support the bladder and kidneys they may recommend a CAT scan or MRI which includes contrast material. These particular x-rays also will illuminate large kidney stones that may require surgery or carcinoma. For the most part noninvasive vascular imaging, including ultrasound, C. T., MRI and radionuclide scanning, has replaced angiography. During this particular test contrast material is injected into the renal vein.

Doppler ultrasound is also widely used to look at the kidneys, latter, prostate and testicles. This particular test is believed to be very safe but provides no information about the function of the kidneys and bladder. Also the quality of the test is dependent specifically upon the individual who is operating machinery. No preparation is needed but having a full bladder will facilitate imaging.

A CT scan will provide a broad view of both the urinary tract system and the surrounding structures. It can be done both with and without contrast material. It is used without contrast for evaluation of trauma or other disorders in which an acute hemorrhage may be expected. An MRI is used to enhance the blood vessels and is a specific task that has virtually replaced angiography in evaluating renal artery stenosis and renal artery thrombosis. It is the best test used for determining the extent of any tumor invasion was in the bladder wall and can identify lymph node metastasis.

Radionuclide scanning is the last particular type of imaging study used by physicians who are evaluating urinary incontinence. In this test contrast is used to image the renal area and provides more information about the interior workings of the kidneys than it does about the function of the kidneys and bladder.

Post-void residual volume is a test which is done to evaluate how much fluid may be left in the bladder after an individual has voided. This particular procedure requires ultrasound and uses catheterization is well. Cystoscopy is a test that performed when urodynamic testing fails to duplicate the symptoms the individual is experiencing or when urinalysis reveals that a specific disease process is underway in the body. It is not an imaging study but helps to identify the presence of other lesions and foreign bodies that can the specifically impact urinary incontinence.

Individuals who suffer from urinary incontinence, overactive bladder or stress incontinence often suffer socially and feel isolated because of their condition. By using specific imaging studies and other diagnostic tests physicians are able to pinpoint reasons why individuals are having these problems and then helped to develop successful treatment protocols that allow individuals greater freedom of movement.

Free PDF Health Ebook...

Learning to Study Effectively - For Students

    Simply right click the ebook title above, and choose Save As to save to your desktop!  You can find more FREE Natural Health, Wellness and Pet Ebooks at Remedies4.com!

About Dee Braun

Dee is an Adv. Certified Aromatherapist, Reiki Master, Adv. Color/Crystal Therapist, Herbalist, Dr. of Reflexology and single mom who is dedicated to helping others any way she can. One way she chooses to help is by offering information on the benefits and uses of natural health and healing methods for the well-being of both people and pets. Dee also teaches Aromatherapy, Reflexology and Color/Crystal Therapy at the Alternative Healing Academy

Source: www.natural-holistic-health.com

Saturday, April 27, 2013

Music for Hearts in Yunnan Province, China

Music for Hearts in Yunnan Province, China

LOS ANGELES, April 27, 2013 /PRNewswire-USNewswire/ -- What does a child prodigy do a few years after all the hoopla has died down? Marc Yu 's answer is, "You know about fame, hard work, and the business dimension. But this is all mixed up with idealism because of your age and because of the nature of music. Or, at least, that's how it worked out for me." Marc, now 14, attends school and continues his musical studies while continuing his commitment to making the world a better place. He started humanitarian activities during his child prodigy days by doing charity fundraisers. While he can reminisce about being on the front page of the LA Times when he was six, or playing for Ellen, Leno and Oprah, and giving concerts for the BBC Proms, he also remembers being able to move people to unselfishly open their wallets for good causes. "Without this, music loses something special – people pay money so musicians can play music so people can pay money... Music becomes another business on a planet full of businesses, and here we are today: in trouble." To Marc, music should explode this cycle, as in the 60's when rock bands led a generation to stop the Vietnam War. "It is not hard to find good causes if you steer clear of the Trending Now! and the stream of advertising."

This summer Marc will merge his idealism with that of Dr. Robert Detrano (UC Irvine) and China California Heart Watch ( China Cal ), a non-profit providing free heart care to the rural people of Yunnan, China's second poorest province. Fund-raising is essential for providing grants to children born with heart problems that would be fatal if left untreated. Marc will be joining one of several intern teams that travel to remote towns and villages where they listen to children's hearts to detect the rhythmic swish-swishes that doctors call heart murmurs. Aside from cardiologist-supervised heart screenings of schoolchildren, interns also help record medical histories, measure heart rate and blood pressure, and assist in ultrasound examinations. China Cal 's work has resulted in over 100 children born with congenital heart defects obtaining life-saving surgery, hundreds of villagers receiving treatment for high blood pressure and heart disease, and over 2000 village doctors being trained in the detection and treatment of heart disease and hypertension. China Cal 's interns are college or medical students drawn by the opportunity to work hands-on with the medically-underserved of rural China, and gain awareness of the problems of healthcare there (described on their website www.chinacal.org).

When he returns to the US, Marc will be doing fewer ultrasounds and more fundraisers, with several concerts planned to raise awareness and funds. Marc knows music will lend drama, urgency, and brotherhood to the cause of fixing congenitally broken hearts.

Contacts:
Chloe Hui +1 (626) 373-7686 chloehui1211@gmail.com 
Amy Wright +86 13759486471 amy@chinacal.org 
Dr. Robert Detrano +86 13708768044 robert@chinacal.org

SOURCE China California Heart Watch ( China Cal )

RELATED LINKS
http://www.chinacal.org


Source: www.prnewswire.com

Friday, April 26, 2013

Maryland Offers Glimpse At Obamacare Insurance Math

Maryland Offers Glimpse At Obamacare Insurance Math

Updated at 5:40 p.m. to add comment from insurers Aetna and UnitedHealthcare.

In the latest preview of prices for health coverage under the Affordable Care Act, Maryland’s dominant insurer says proposed premiums for new policies for individuals will rise by 25 percent on average next year.

That’s lower than what some had predicted. Just three weeks ago, the insurer, CareFirst BlueCross BlueShield, had been looking at a proposed 50 percent increase. But the company revised that initial estimate, citing worries about affordability for consumers.

“Not only were we concerned about a potential hit to subscribers, but we were also concerned about price levels that were unattractive” to young customers seen as an important stabilizing force for the market, CareFirst CEO Chet Burrell said in an interview Wednesday.

 

Late Tuesday Maryland regulators posted proposed rates and benefits for health plans to be sold through an online exchange,  a step required under the health act, known as the Maryland Health Connection.

Maryland is an important state to watch because it has embraced Obamacare’s insurance reforms, setting up its own marketplace. But there have been serious concerns that the insurance offered there — and on every other exchange across the country — might be too expensive for people to buy.

While most Marylanders younger than 65 have health plans through employers, the exchange’s plans for individuals and small employers are expected to play a key role in bringing coverage to the state’s 700,000 uninsured. That’s about 12 percent of the state’s population.

Many have warned that guaranteeing coverage at regulated prices for sick people would drive up the cost of insurance in the individual market. The ACA prohibits charging sicker members substantially more but allows plans to adjust premiums for age and other factors, within strict limits.

Taking those factors into account, CareFirst premiums for individual plans could rise as high as 150 percent next year for healthy young men and decrease slightly for someone older and sicker, Burrell said.

One current popular CareFirst plan with a $2,700 deductible costs “less than $115 per month” for men under 30, said Mark Hammett, a broker at Kelly & Associates Insurance Group in Hunt Valley, Md.

Consumer advocates were reluctant to draw conclusions from the raw rate filings for the exchange, which make it difficult to quote proposed prices for specific individuals. And they cautioned that filings by CareFirst and other carriers are only preliminary.

“Now the regulators take a look and say, ‘How do you justify these increases?’” said Kathleen Stoll, director of health policy for the pro-ACA consumer group Families USA. “That often results in a reduction to the proposed charges.”

Although prices may rise for some, benefits may be better and many will receive federal subsidies to pay the premiums, she said. Families USA estimates that some 361,000 Marylanders will be eligible for tax credits to pay insurance costs.

“Some people may actually spend much less out of pocket… and end up with a much better product and a much better situation to protect their family from financial devastation from illness,” she said.

That distinction may be initially lost on those focusing only on the premiums, however.

“To the average consumer who has insurance now, the rates will feel every bit like a rate increase,” said Joseph Antos, a health economist at the right-leaning American Enterprise Institute.

CareFirst owns about 70 percent of Maryland’s individual insurance market, with about 120,000 members. Even most of them — 60 percent — won’t see the kind of increases CareFirst proposes because they’re in older, “grandfathered” plans that don’t have to comply with some requirements of the health law yet, Burrell said.

CareFirst and other carriers also filed plans for small employers, but because Maryland had already implemented small-group reforms similar to those that are included in the ACA, those prices weren’t expected to change much. For years Maryland has prohibited insurers from charging substantially more to small employers with sicker and older workforces.

Premiums for CareFirst’s small employer plans to be offered on the exchange next year are proposed to rise about 15 percent, Burrell said, mainly because of the rising cost of health care.

Burrell dismissed a reporter’s suggestion that Democratic Gov. Martin O’Malley, who has much riding on the success of the ACA in Maryland, might have pressured CareFirst to lower its initial filing premiums.

“Nobody asked,” he said. “We did it of our own volition.”

Maryland law requires the nonprofit CareFirst to promote health care affordability and accessibility. With the new, lower projected premiums, Burrell said, “we’re not expecting to make money. We’re expecting to lose money. If we’re going to lose it we’re going to lose it on behalf of subscribers and the community.”

Besides CareFirst, Kaiser Permanente, Aetna, UnitedHealthcare, Coventry Health and Evergreen Health Cooperative all filed to offer about 50 individual or small group plans on the exchange.

An Aetna spokesman said proposed premiums for Maryland small group plans would rise between 12 and 16 percent next year. United proposed average small group increases of from 15 to 28 percent, but premium changes could vary widely depending on the plan, said company spokesman Matt Stearns.

Aetna didn’t say what the average increase for individual plans would be. United hasn’t filed applications yet for Maryland individual plans.

“We currently offer individual coverage in Maryland, and we expect to do so next year,” United's Stearns said.

The O’Malley administration also stressed that the filings are not the final word on insurance prices under the health law.

 “It is premature to reach any judgment or conclusion based on the rates as proposed,” said Carolyn Quattrocki, director of the Governor’s Office of Health Care Reform. “In the meantime, we are pleased that the filings confirm there will be robust participation in the Maryland Health Connection.”


Source: feeds.kaiserhealthnews.org

Gardening on the Cheap: Your Guide to Getting Started this Spring

Gardening on the Cheap: Your Guide to Getting Started this Spring
By Ellen Jaffe Jones, Guest Contributor  My daughter recently said to me, “Mom , I hate to eat tomatoes at restaurants. I keep remembering how delicious and sweet the tomatoes were that we used to grow in our organic garden. Most tomatoes I taste now pale by comparison.” This was the same child who wowed
Photo by Ellen Jaffe Jones

Photo by Ellen Jaffe Jones

By Ellen Jaffe Jones, Guest Contributor 

My daughter recently said to me, “Mom , I hate to eat tomatoes at restaurants. I keep remembering how delicious and sweet the tomatoes were that we used to grow in our organic garden. Most tomatoes I taste now pale by comparison.”

This was the same child who wowed the nursery school field trip farmer by knowing the difference when he tried to stump the kids holding up the green kale leaf and asking: “What’s this?” All the other kids yelled, “Spinach!” It was my daughter who tasted sugar snap peas for the first time and asked, “Is this candy?”

“Teach Your Children Well,” as the Crosby, Stills, Nash and Young song goes. Children respond so well to early tactile and taste stimulations. If they are imprinted with early tastes for foods in their natural states, it stays with them the rest of their lives.

Having a garden is the best way to introduce them to nature and understanding that food doesn’t grow in a shrunk-wrapped package at the grocery store. As the snow (hopefully) melts, and the scents of spring beckon children outside, starting a cheap garden is a great way to keep them outside.

The first step is taking a soil sample to your local county extension service to get an analysis of your soil. This will give you a place to start in figuring out what you can and can’t grow well in your soil. Soil that is mostly sand may only be able to support citrus crops, for example, but soil just a little farther inland can give you half a year of a great cross-section of vegetables.

It’s easier to grow a garden from plants that are already started and are ready to transplant.  But it’s also fun for kids to start seeds from starter pots. If getting non-gmo seeds are important for you, try www.seedsofchange.com. They’ll also provide tips on how to start your own garden. You can also join a local farm or community supported agriculture farm to find out where they get their seeds from. You can find them at www.localharvest.org.

IMG_0497

Photo by Ellen Jaffe Jones

If you don’t know anything about gardening, spend a season volunteering at a local farm to see how and what they do. You’ll also get first-hand knowledge about what grows well where you are. If it is an organic garden, you’ll learn all kinds of great ways to make and keep your garden organic. If you can’t find such a farm, there are many great organic and container gardening books and online resources. Don’t give up if you run in to failures – just remember that it is to be expected.

It’s best to choose just 3-4 vegetables your first year. Pick some vegetables like tomatoes that grow fast and furious.  Some varieties will “re-seed” themselves. That means their seeds will drop into the soil and grow again the next year –talk about easy! Learn what crops grow especially easily where you are. I planted a few pumpkin seeds one year, and once I figured out how to keep out the rabbits, I had pumpkin vines and pumpkins taking over the yard and a nearby hill. It was SO much fun for me and my children!

Try planting a few easy herbs like dill and mint. They are also classified as weeds and will definitely grow like one if you don’t control them. Send your children out to the garden before dinner when they are hungry to “harvest” whatever you’ll be making for dinner. These are memories and foods that will last a lifetime!

It’s always cheaper to start a garden from seed than buy plants that are already started at a store. But whatever works for your budget and convenience. The key is to just get one started and to keep it simple. Happy spring!

About the Author:

Ellen_Jaffe_Jones_new

Ellen Jaffe Jones has been an organic gardener since her dad taught her to pick dandelions by hand as a child. She’s an accomplished runner (3rd in FL in multiple track events) the author of “Eat Vegan on $4 a Day,” a certified personal trainer (AFAA), running coach (RCCA) and popular national speaker.


Source: feedproxy.google.com

BD gibt FDA 510(k)-Zulassung und Markteinführung des passiven Nadelschutzsystems BD UltraSafe PLUS™ bekannt

BD gibt FDA 510(k)-Zulassung und Markteinführung des passiven Nadelschutzsystems BD UltraSafe PLUS™ bekannt

-- Das neue Sicherheitssystem ist auf die Bedürfnisse biologischer Präparate zugeschnitten

FRANKLIN LAKES, New Jersey, 26. April 2013 /PRNewswire/ -- BD Medical, ein Geschäftsbereich von BD (Becton, Dickinson and Company) (NYSE: BDX) und ein weltweit führendes Medizintechnikunternehmen, hat heute die Markteinführung seines neuen passiven Nadelschutzsystems BD UltraSafe PLUS™ bekannt gegeben. Das passive Nadelschutzsystem BD UltraSafe PLUS™ hat die 510(k)-Zulassung als Sicherheitssystem gegen Nadelstichverletzungen erhalten.

Neben dem Schutz gegen Nadelstichverletzungen in einem einfach zu bedienenden Einhand-Gerät bietet das Produkt ergonomische Verbesserungen für mehr Injektions-Komfort für Ärzte wie für Patienten. Darüber hinaus ist das Sicherheitssystem dafür konzipiert, zunehmend komplexe, biotechnologische Anforderungen hinsichtlich der Medikamente, wie eine höhere Viskosität, zu erfüllen.

„Wir freuen uns sehr, das neue passive Nadelschutzsystem BD UltraSafe PLUS™ anzubieten, das unser aktuelles Sicherheitsportfolio hervorragend ergänzt", erklärte Claude Dartiguelongue, Präsident von BD Medical - Pharmaceutical Systems. „Wir verfügen jetzt über eine ergonomische Sicherheitslösung für Kunden, die ihren Patienten die Möglichkeit bieten möchten, die Injektion manuell zu kontrollieren."

Das passive Nadelschutzsystem BD UltraSafe PLUS™ bietet zahlreiche erweiterte Funktionen, beispielsweise eine robuste Kolbenstange zur Injektion viskoser Medikamente, ein größeres Sichtfenster zur verbesserten Sichtbarkeit der Arznei, breitere Flansche und einen verbesserten Kolbenkopf für mehr Unterstützung und Stabilität bei der Injektion. Diese ergonomischen Verbesserungen kommen allen Benutzern zugute, insbesondere Patienten mit verminderter Fingerfertigkeit. BD hat kürzlich eine klinische Schwerpunktuntersuchung mit Patienten durchgeführt, deren Fingerfertigkeit vermindert war und die unter rheumatoider Arthritis und Multipler Sklerose litten. Die Testpersonen berichteten, das passive Nadelschutzsystem BD UltraSafe PLUS™ sei sehr benutzerfreundlich. 100% der Injektionen wurden erfolgreich durchgeführt.

„Das neue, passive Nadelschutzsystem BD UltraSafe PLUS™ wurde so konzipiert, dass es einfach in bestehende Verpackungslinien für Sicherheitssysteme integriert werden kann und es ist mit vorgefüllten Fertigspritzen nach ISO-Norm kompatibel", fügte Peter Nolan , Vice President, Safety bei BD Medical – Pharmaceutical Systems hinzu.

Das passive Nadelschutzsystem BD UltraSafe PLUS™ ist darauf ausgelegt, mit 1,0 mL Long, Fertigspritzen mit eingeklebter Nadel wie BD Hypak™ oder BD Neopak™ verwendet zu werden. Das Produkt wurde von Safety Syringes, Inc., einem Unternehmen für Nadelschutzsysteme, entwickelt, das BD im Dezember 2012 übernommen hat. Das passive Nadelschutzsystem BD UltraSafe PLUS™ hat zahlreiche positive Rückmeldungen erhalten, nachdem es den Kunden im Oktober 2012 anlässlich der Tagung der Parenteral Drug Association präsentiert worden war. Es sind bereits Bestellungen eingegangen, und mit der kommerziellen Auslieferung des passiven Nadelschutzsystems BD UltraSafe PLUS™ soll in Kürze begonnen werden.

Informationen zu BD
BD ist ein führendes, weltweit tätiges Medizintechnikunternehmen, das medizinische Geräte, Instrumente und Reagenzien entwickelt, produziert und vertreibt. Das Unternehmen setzt sich für die Verbesserung der Gesundheit der Menschen weltweit ein. Der Schwerpunkt von BD liegt auf der Verbesserung der Wirkstoffverabreichung, der Qualität und einer schnellen Diagnose von Infektionskrankheiten und Krebs sowie auf der Erforschung, Entdeckung und Herstellung neuer Medikamente und Impfstoffe. Die Arbeit von BD trägt maßgeblich zur Bekämpfung vieler der weltweit schwersten Erkrankungen bei. BD wurde 1897 gegründet und hat seinen Hauptsitz in Franklin Lakes, New Jersey. Das Unternehmen beschäftigt rund 30.000 Mitarbeiter in über 50 Ländern auf der ganzen Welt. Das Unternehmen bietet seine Produkte Gesundheitseinrichtungen, Biowissenschaftlern, klinischen Labors, der Pharmaindustrie und der allgemeinen Öffentlichkeit an. Weitere Informationen finden Sie auf www.bd.com.

Kontakt:
Jamie Yacco
Öffentlichkeitsarbeit
+1-201-847-4796
Jamie_Yacco@bd.com

SOURCE BD-Becton Dickinson

RELATED LINKS
http://www.bd.com


Source: www.prnewswire.com

Thursday, April 25, 2013

The 5 Things About Diet a Psoriasis Sufferer Must Know

To keep psoriasis flares at bay, ensuring adequate rest, managing stress, regular exercise, as well maintaining a healthy diet is very important when trying to overcome the illness. It is essential to Psoriasis sufferers to help control the condition by following a proper psoriasis diet. Complete article

Los dirigentes mundiales apoyan un nuevo plan de seis años para lograr un mundo libre de la poliomielitis en 2018

Los dirigentes mundiales apoyan un nuevo plan de seis años para lograr un mundo libre de la poliomielitis en 2018

-- Las promesas anunciadas facilitarán la vacunación de más de 100 millones de niños y niñas

-- El programa para la erradicación mundial avanzará simultáneamente en varios frentes, ampliando el enfoque para mejorar la inmunización infantil y proteger los logros conseguidos hasta la fecha.

-- Los nuevos compromisos de los gobiernos y de las personas filantrópicas impulsan el esfuerzo para lograr la meta presupuestaria del plan

ABU DHABI, Emiratos Árabes Unidos, 25 abril de 2013 /PRNewswire/ -- Hoy, durante la Cumbre Mundial de las Vacunas, la Iniciativa Mundial para la Erradicación de la Poliomielitis (GPEI) presentó un plan integral de seis años, el primero orientado a erradicar simultáneamente todos los tipos de la enfermedad de la poliomielitis, tanto el virus salvaje de la poliomielitis como los casos derivados de las vacunas. Los dirigentes mundiales y los individuos dedicados a la filantropía destacaron su confianza en el plan y prometieron cerca de tres cuartas partes de los 5.500 millones de dólares presupuestados para plan durante seis años. También exhortaron a otros donantes a que comprometan por adelantado los 1.500 millones de dólares necesarios para garantizar la erradicación.

El nuevo plan capitaliza una gran oportunidad para erradicar la poliomielitis, ya que el número de niños y niñas paralizados por esta enfermedad se encuentra en su nivel más bajo, 223 en 2012 y 19 hasta la fecha durante este año. La urgencia se debe a que se han producido grandes avances en 2012 y a que la ventana de oportunidad es limitada para aprovechar estos progresos y poner fin a la transmisión del virus de la poliomielitis antes de que los países que están libres de esta enfermedad vuelvan a sufrir nuevas infecciones. 

"Después de varios milenios combatiendo la poliomielitis, éste plan nos coloca muy cerca del fin de todo el proceso. Tenemos nuevos conocimientos sobre los virus de la poliomielitis, nuevas tecnologías y nuevas tácticas para llegar a las comunidades más vulnerables. La amplia experiencia, la infraestructura y los conocimientos obtenidos en la tarea de poner fin a la poliomielitis nos pueden ayudar a llegar a todos los niños y a todas las comunidades con servicios esenciales de salud", dijo la Directora General de la Organización Mundial de la Salud, Margaret Chan .

Un nuevo plan para poner fin a la poliomielitis, reforzar los sistemas de inmunización y planificar la transición

El Plan estratégico para la erradicación de la poliomielitis y la fase final 2013-2018 fue elaborado por la iniciativa GPEI después de amplias consultas con numerosas partes interesadas. El plan se basa en las lecciones aprendidas en la exitosa campaña para conseguir eliminar la poliomielitis en la India a comienzos de 2012, incorpora conocimientos de vanguardia sobre el riesgo que supone la circulación de los virus de la poliomielitis derivados de vacunas, y complementa los Planes de Acción de Emergencia selectivos que desde el año pasado se han puesto en práctica en el resto de los países donde la poliomielitis es endémica –Afganistán, Pakistán y Nigeria– incluidos los enfoques actuales para vacunar a los niños y niñas en zonas inseguras. 

En la Cumbre, celebrada hoy Abu Dhabi, los dirigentes mundiales anunciaron su confianza en la capacidad del plan para lograr un mundo libre de la poliomielitis para 2008 y comprometieron su apoyo financiero y político para su puesta en práctica.

"Poner fin a la poliomielitis no solamente será un logro histórico para la humanidad, sino también una parte importante de nuestros esfuerzos para llegar a todos los niños y niñas que viven en los lugares más remotos con un conjunto de vacunas que salvan vidas", dijo el Director Ejecutivo de UNICEF Anthony Lake.

El plan aborda los problemas operativos que supone vacunar a los niños en las zonas urbanas densamente pobladas, en las zonas muy remotas y en las zonas inseguras. El plan incluye la utilización de la experiencia y los recursos empleados en la erradicación de la poliomielitis para fortalecer los sistemas de vacunación en los países más prioritarios. También define un proceso para planificar la manera de realizar una transición de los recursos y las lecciones de la iniciativa GPEI, especialmente en la tarea de llegar a los niños y las comunidades más marginados y vulnerables, para que puedan seguir sirviendo en otros empeños de salud pública. Se calcula que las actividades del GPEI para erradicar la poliomielitis podrían generar beneficios netos totales de 40.000 a 50.000 millones de dólares en 2035, debido a la reducción en los costos de tratamiento y a los avances en la productividad. 

A comienzos de este mes, en una Declaración Científica sobre la Erradicación de la Poliomielitis, más de 400 científicos y expertos mundiales de salud de todo el mundo apoyaron el plan de la iniciativa GPEI, y reafirmaron la convicción de que se puede lograr un mundo libre de la poliomielitis en 2018.

Los filántropos apoyan el valor que se deriva de invertir en el fin de la poliomielitis

En declaraciones realizadas durante la Cumbre, Bill Gates , copresidente de la Fundación Bill y Melinda Gates , destacó los numerosos beneficios que supone poner fin a la poliomielitis y la necesidad de proporcionar intervenciones de salud y de desarrollo a los niños y niñas a quienes resulta más difícil llegar. También exhortó a otros donantes a que presenten compromisos a largo plazo para financiar plenamente el plan de la iniciativa GPEI.

"Este plan no solamente se refiere a la erradicación de la poliomielitis, es un plan mundial de inmunización con el objetivo de poner fin a la poliomielitis y al mismo tiempo mejorar los esfuerzos para proteger a todos los niños y niñas, incluidos los más vulnerables, con vacunas que salvan vidas", dijo Gates.  "Una aplicación con éxito del plan exige una inversión considerable pero limitada en el tiempo, que impulsará un mundo libre de la poliomielitis y ofrecerá dividendos para las generaciones futuras"

Gates anunció que su fundación se comprometerá con una tercera parte del coste total del presupuesto de la GPEI durante la ejecución de seis años del plan, por un total de 1.800 millones de dólares. Los fondos se asignarán con el fin de facilitar que la GPEI pueda operar con eficacia en el logro de todos los objetivos del plan. A fin de alentar a otros donantes a que comprometan por adelantado los fondos restantes, la financiación de Gates para 2016-2018 se dará a conocer sólo cuando la GPEI obtenga la financiación necesaria que asegure que la aportación de la fundación no exceda una tercera parte del presupuesto total para esos años.

A Gates se unió un nuevo grupo de filántropos que anunciaron su apoyo a la puesta en práctica de este nuevo plan. El total de las nuevas promesas de los filántropos a la iniciativa de la poliomielitis supone 335 millones de dólares adicionales para el presupuesto de seis años del plan. Los donantes aplaudieron los grandes progresos realizados hacia la erradicación durante este último año, y su deseo de contribuir a cambiar la historia y eliminar la poliomielitis mientras siga existiendo la oportunidad. Los compromisos incluyen:

Fundación Albert L. Ueltschi
Fundación Mundial Alwaleed Bin Talal
Bloomberg Philanthropies
Fundación Carlos Slim
Fundación Dalio
La Fundación para una Gran Oportunidad, establecida por Carl C. Icahn
La Fundación Tahir

Un plan plenamente financiado y un compromiso político sostenido protegerán los avances alcanzados hasta la fecha y permitirán a la iniciativa GPEI realizar sus objetivos a corto y a largo plazo

Durante la Cumbre , los dirigentes de los países donde la poliomielitis es endémica reafirmaron que siguen centrándose en la erradicación de la poliomielitis y acogieron con beneplácito el amplio alcance del plan para mejorar los sistemas de inmunización.

Al tiempo que encomiaban el enfoque ampliado del plan para garantizar las actividades de erradicación de la poliomielitis –que llegan a los niños y niñas más vulnerables del mundo– y apoyar intervenciones más amplias de salud, donantes de larga data como Alemania, Canadá, Noruega y el Reino Unido, así como Nigeria, anunciaron su apoyo al plan con nuevos compromisos para apoyar los objetivos a largo plazo del proyecto. Su Alteza Sheikh Mohamed bin Zayed Al Nahyan , el Príncipe Heredero de Abu Dhabi y Comandante Supremo Adjunto de las Fuerzas Armadas de los Emiratos Árabes Unidos, anunció un segundo compromiso con la erradicación de la poliomielitis por valor de 120 millones de dólares, que se suman a su primera contribución, realizada en 2011. Otros donantes, incluidos el Banco Islámico de Desarrollo, Irlanda y el Japón, ayudaron a redondear los compromisos adicionales. 

Rotary International, el principal donante del GPEI, se comprometió a aumentar los fondos hasta 2018 y movilizar el apoyo a la estrategia para llegar al punto final. "Para poner fin a la poliomielitis de una vez por todas tenemos que actuar rápidamente a fin de que los niños y las niñas estén plenamente protegidos y los países no se vuelvan infectar", dijo el Presidente de Rotary International, Sakuji Tanaka . "Esto exige el compromiso de los dirigentes nacionales y locales en los lugares donde todavía existe la poliomielitis, así como el apoyo continuo de los países donantes y el compromiso sin fisuras de los heroicos vacunadores".

La GPEI trabajará con los donantes para transformar de manera oportuna de estas promesas en compromisos y acelerar el desembolso de los fondos para que el programa pueda aplicar plenamente este plan.

El presupuesto de 5.500 millones de dólares durante seis años exige un gasto anual sostenido para erradicar la poliomielitis. El nuevo presupuesto del plan incluye los costos de llegar y vacunar a más de 250 millones de niños y niñas varias veces todos los años, de realizar una tarea de seguimiento y vigilancia en más de 70 países, y de garantizar la infraestructura que pueda beneficiar otros programas de salud y desarrollo.

"Hoy en día tenemos la menor cantidad de casos en la menor cantidad de lugares, un hecho sin precedentes, y esto hace que sea fundamental aprovechar la mejor oportunidad que ha tenido el mundo hasta la fecha para poner fin a esta enfermedad terrible que se puede evitar", dijo la Dra. Anne Schuchat , Jefa del Centro para la Salud Mundial de los Centros de los Estados Unidos para el Control y la Prevención de las Enfermedades.

Notas para los editores:

El Plan fue creado por la GPEI después de realizar amplias consultas con las autoridades nacionales de salud, las iniciativas mundiales de salud, expertos científicos, donantes y otras partes interesadas. Los cuatro objetivos principales del plan incluyen: 1) Detección e interrupción del virus de la poliomielitis; 2) Sistemas para reforzar la inmunización y la retirada de la vacuna oral de la poliomielitis; 3) Contención y certificación; 4) Planificación del legado.

La circulación del virus de la poliomielitis derivado de la vacuna: En muy raras ocasiones, el virus de la poliomielitis vivo y debilitado que contiene la vacuna oral contra la poliomielitis puede alterarse genéticamente en el intestino de la persona inmunizada. Si una población sufre una grave insuficiencia de vacunación, el virus puede empezar a circular en la comunidad (se trata de virus de la poliomielitis derivados de las vacunas en circulación (cVDPV). Entre los años 2000 y 2011, un período en el que se administraron más de 10 millones de dosis de la vacuna antipoliomielítica oral en todo el mundo, los brotes de cVDPV produjeron 580 casos de polio. En el mismo período, el virus salvaje de la poliomielitis paralizó a más de 15.500 niños. Sin embargo, a medida que el virus salvaje de la poliomielitis declina, se eleva la proporción de cVDPV en las comunidades donde la inmunidad es reducida. El nuevo plan utiliza los conocimientos de vanguardia sobre estos virus y nuevas tácticas para aumentar la inmunidad, entre ellas la introducción de la vacuna antipoliomielítica inactivada y la eliminación del uso de los componentes de la vacuna oral contra la poliomielitis, que da lugar a la mayoría de los casos de cVDPV. Si una población está totalmente inmunizada contra la poliomielitis, estará protegida contra la propagación de cepas salvajes y de las vacunas del virus de la polio.

Otros recursos:

Desglose de las promesas al presupuesto de la GPEI 2013-2018

Resumen Ejecutivo del Plan Estratégico para la Erradicación de la Poliomielitis y la Fase Final – http://www.polioeradication.org/Portals/0/Document/Resources/StrategyWork/PEESP_ES_EN_A4.pdf

Hoja de datos del Plan Estratégico para la Erradicación de la Poliomielitis y la Fase Final http://www.polioeradication.org/Portals/0/Document/Resources/StrategyWork/GPEI_Plan_FactFile_EN.pdf

Recursos para los medios de comunicación de la Cumbre Mundial de las Vacunas – www.globalvaccinesummit.org

Sobre la GPEI

La Iniciativa Mundial para la Erradicación de la Poliomielitis (GPEI), iniciada en 1988, está compuesta por gobiernos nacionales, la Organización Mundial de la Salud (OMS), Rotary International, los Centros de los Estados Unidos para el Control y la Prevención de las Enfermedades (CDC) y UNICEF; también recibe el apoyo de aliados como la Fundación Bill y Melinda Gates

Desde sus comienzos, la incidencia de la poliomielitis se ha reducido en más de un 99%. En 1988, más de 350.000 niños y niñas quedaban paralizados todos los años en más de 125 países endémicos. Hoy en día, solamente tres países siguen siendo endémicos: Nigeria, Pakistán y Afganistán. El año pasado, los casos del virus salvaje de la poliomielitis descendieron de 650 en 2011 a 223, la mayor reducción en una década. Hasta el 17 abril se han registrado 19 casos, una reducción del 60% en comparación con lo que ocurría el año pasado para estas fechas.  

SOURCE Global Polio Eradication Initiative

RELATED LINKS
http://www.polioeradication.org


Source: www.prnewswire.com

Wednesday, April 24, 2013

There Must Be a Better Way: On Conventional Healthcare and the Vegan Patient

There Must Be a Better Way: On Conventional Healthcare and the Vegan Patient
Things I would rather do than attend my scheduled doctor’s appointment this morning: get audited by the IRS or watch paint dry for a few hours. To put it lightly, I am not a huge fan of visiting my doctor – not because she is unfriendly or incompetent, but because the whole process – so
Photo by StockImages/Freedigitalphotos.net

Photo by StockImages/Freedigitalphotos.net

Things I would rather do than attend my scheduled doctor’s appointment this morning: get audited by the IRS or watch paint dry for a few hours. To put it lightly, I am not a huge fan of visiting my doctor – not because she is unfriendly or incompetent, but because the whole process – so often being labeled as an insurance claim number, sitting in a cold room only to be prodded by cold instruments, and being forced to hear a sales pitch about the latest prescription drug (which was more than likely tested on animals and coated in gelatin, or, in other words, ground animal bones) that will supposedly help improve my life. Yes, though I know medical treatment is a necessary part of life, I’ve never loved the process, especially as a vegan who is skeptical of conventional healthcare practices. If only there was an alternative…

Oh, wait – there is. Naturopathic medicine, which focuses on holistic prevention and healing, often looks to conventional prescription medication as a last result to one’s bodily troubles. N.D.s often run smaller practices so they can consult for long periods of time with their patients – analyzing sleep patterns, external environments, and stress levels. As opposed to automatically buying in to the non-so-vegan-friendly world of prescription medication, N.D.s typically seek out natural, minimally toxic responses to bodily issues. In other words, as a vegan, you’re less likely to be presented with an array of pills and more likely to be talked to and treated as a human being with many factors contributing to your body’s functions. What’s more is that the typical N.D. is trained in everything an M.D. is (and more) – according to the American Association of Naturopathic Physicians, “A licensed naturopathic physician (ND) attends a four-year, graduate-level naturopathic medical school and is educated in all of the same basic sciences as an MD, but also studies holistic and nontoxic approaches to therapy with a strong emphasis on disease prevention and optimizing wellness. In addition to a standard medical curriculum, the naturopathic physician is required to complete four years of training in clinical nutrition, acupuncture, homeopathic medicine, botanical medicine, psychology, and counseling (to encourage people to make lifestyle changes in support of their personal health). A naturopathic physician takes rigorous professional board exams so that he or she may be licensed by a state or jurisdiction as a primary care general practice physician.”

According to the Association of Accredited Naturopathic Colleges, there are approximately 3500 practicing N.D.s in the United States Today – this presents many opportunities for a concerned vegan like myself to have a better healthcare experience. But, alas, I can’t see one of them – or not without paying for the visit myself, anyway.

While the healthcare insurance system already is problematic, my otherwise very extensive national insurance carrier simply doesn’t acknowledge a trip to the N.D. as anything more than an “alternative treatment,” one which I would be responsible for financially. N.D. work is called everything from “quack science” to flat-out “fake.” But, for a well-informed vegan skeptic like myself, this is no less than frustrating. Sure, there are probably less-than-credible alternative practices and practitioners out there, but I want to visit an N.D. for my health needs as I age. As a health-concerned person, my focus is on prevention — and an N.D. practice acknowledges this. Many N.D.s are vegans or vegetarians themselves – a worthy alternative to visiting a slew of seemingly unhealthy conventional doctors. Why would I take pills prescribed from someone I don’t align my values with? How can I turn a blind eye to the atrocities of prescription drug animal testing and know how many standard M.D.s prescribe drug after drug on a daily basis?

Healthcare is changing, I know, but, no matter what happens, I feel as though N.D.s should be covered under most insurance plans the same way M.D.s are – for vegans and health-conscious citizens such as myself, I can finally work with someone concerned about the holistic progression of my body, the way nature intended — no sales pitch included.


Source: feedproxy.google.com

Reasons Why Supplements Are Important

Reasons Why Supplements Are Important

Supplements are defined as dietary additives that are taken by people in order to ensure they get those nutrients that they did not have in their diet. Some countries define them as foods but they are commonly called drugs. The content includes vitamins and minerals which may luck in the diet an individual takes.

Something that is not commonly known regards these drugs is that a prescription is required. Before you take them, you need to have knowledge on how many pills you should take and after what duration of time. They should not be ingested just anyhow but with the direction of a qualified pharmacist.

Finding the best place to get them from is not a very easy task. Not just every pharmacy in town will have the best ones for you. A number of factors need to be considered before you set out to purchase them. Here are some tips to guide you to an excellent buying point.

Where you decide to buy them from determines the quality of drugs you get. You therefore need to go to a place that stocks high quality medicines. The quality is not very difficult to tell. They should not have any drugs that do not have marks of quality or do not meet the standards set by the state.

Something that maintains the quality of drugs is the storage. With proper storage the nutritional value of the items are maintained throughout. No value will be lost at all. Refrigeration is required for some drugs. Buy them from a pharmacy that has the best storage and hygiene. This will be safe for your health.

To help you select the best drugs suitable for you, you need the help of a qualified pharmacist. The guidance such an individual will provide will be invaluable. Find a place with one who is qualified to give the assistance you require. Unless you are a physician yourself, it would be hard to make the decision by yourself.

After finding the best place to buy the supplements from, there is one thing you should not forget. Those drugs are only to supplement your diet not replace it. Continue eating a healthy diet as normal. Do not stop eating well just because you have bought the drugs. Maintain a healthy diet and lifestyle all through.

Want more information, visit this site Berocca and Green Lipped Mussel


Source: www.thehealthdirectoryonline.com

Sephora Cabana Cutie Kit

Sephora Cabana Cutie Kit
While the weather may not be so bright and sunny outside, the new Sephora Cabana Cutie Kit ($18 USD / $22 CAD) makes me feel like it is. This cute duo contains a color-adjusting lip balm and a mini MicroSmooth Baked Bronzer. Where’s my beach towel!? Copyright © Beautezine, 2013. | Original Post | No comment [...]
Sephora Cabana Cutie Kit

While the weather may not be so bright and sunny outside, the new Sephora Cabana Cutie Kit ($18 USD / $22 CAD) makes me feel like it is. This cute duo contains a color-adjusting lip balm and a mini MicroSmooth Baked Bronzer.

Where’s my beach towel!?


Copyright © Beautezine, 2013. | Original Post | No comment | Twitter | Facebook
Categories: Daily Beauty
Tags: , , , , , , , , ,


Source: feedproxy.google.com

Mercy and Trapollo Partner on Groundbreaking, Large-Scale Remote Patient Monitoring Program

Mercy and Trapollo Partner on Groundbreaking, Large-Scale Remote Patient Monitoring Program

STERLING, Va., April 24, 2013 /PRNewswire/ -- In an effort to reduce hospital readmissions, Chesterfield, Mo., based Mercy has contracted Trapollo LLC., to provide a complete managed service offering designed specifically for remote health monitoring programs. 

Throughout the duration of the 36-month contract, Trapollo's experienced staff will use proven processes, custom built systems and centralized facilities to implement all non-clinical aspects of the Mercy program. Trapollo will manage all assets and logistics, in-home installations, patient and clinician training, daily customer and technical support, and patient-to-patient transfers of the equipment.  

The technology Mercy selected for this program is designed and manufactured by Philips with its hub device, or TeleStation, paired with a blood pressure monitor, weight scale and glucose meter. Using the Philips devices, Trapollo builds customized kits based on diagnosis and ships them to a patient's home where Trapollo personnel install it, teach the patient how to use it and support all components while in use. 

Once the patient meets Mercy's criteria to graduate from the program, Trapollo schedules the removal and receives the equipment into the Trapollo distribution center. At this time, the devices are disinfected to industry standards, recalibrated and tested, and made ready to ship to another Mercy patient's home.  This process repeats every 90 days and should prove to be instrumental in reducing hospital readmissions.  The program is targeted to touch 12,000 patients over the course of the three-year contract.

Mercy is no stranger to disease management and remote monitoring programs.  Its Heart Failure Resource Center (HFRC) first began enrolling patients in the Springfield community in February 2012 and is currently extending to patients in 35 cities across 4 states. The HFRC strategy consists of a centralized group of registered nurses with cardiovascular-specific experience delivering care to congestive heart failure patients using available technology in the market.  However, the demand of everyday logistics on its nursing staff for a program of this magnitude caused Mercy to regroup and develop a new approach. This new approach has become the differentiator to the success of the program: outsourcing the non-clinical operations. 

The Mercy program is an aggressive approach to educate chronically ill patients on how to better manage their conditions from the comfort of their home.  In order for it to succeed, the equipment had to be installed in the patient's home and supported throughout the enrollment.  The partnership between Trapollo and Mercy creates a solid foundation for one of the largest residential telehealth programs in US history.  Sizable deployments of remote monitoring technology have not often been seen in the market due to lack of logistical support in healthcare organizations.  By teaming with Trapollo, Mercy has overcome this obstacle allowing the Mercy HFRC to remain focused on offering an excellent standard of care to its patients.  

When asked about the program, Trapollo CEO Todd Leto said, "The remote health monitoring market is continually introducing new ideas, processes and devices to both the patients and the clinical staff.  If the program is not designed with ease of use and adoption in mind, it will not run seamlessly thus losing support from all involved.  The benefits of remote monitoring are proven, but so are the obstacles surrounding large scale programs. Trapollo has continued to master our managed service offering to overcome these obstacles and truly enable remote healthcare.  Our partnership with Mercy confirms our shared commitment to the wellness and education of patients. Furthermore, it demonstrates how two forward-thinking organizations working together can create successful connected health programs by managing the details and staying focused on the overall goal of supporting the patient." 

"At Mercy, we are taking steps to reduce costly hospital readmissions but couldn't do it alone," said Sandy Sidoli , executive director of Ambulatory Care Management at Mercy. "We have been very impressed with Trapollo and the processes it has in place to manage our large-scale remote health monitoring program."

The Mercy/Trapollo collaboration to provide remote health monitoring to enhance patients' quality of life will become a benchmark for developing and implementing large complex programs of this nature.  By working together, Mercy and Trapollo have created a streamlined workflow that solves the most well-known obstacle for widespread adoption of residential remote monitoring:  managing the logistics and supporting the patients' in-home technology.  By focusing on what both organizations do best, everyone involved will benefit in the end, first and foremost the patient. 

Contact:
Kristen Tiede
(703) 434-3071
Kristen.tiede@trapollo.com

SOURCE Trapollo LLC


Source: www.prnewswire.com

Tuesday, April 23, 2013

An Irritable Bowel Syndrome Natural Treatment

An Irritable Bowel Syndrome Natural Treatment
Seeking an irritable bowel syndrome natural treatment?

Irritable bowel syndrome is classified as a spastic colon disorder, because the muscular contractions of the bowel become irregular. It is the most common digestive disorder among American adults, and now, it's becoming common in children as well. Crohn's Disease, colitis, and celiac disease have very similar symptoms, but they fall into the inflammatory bowel disorder category, which is due to the breakdown of the intestinal mucosa.

Symptoms of irritable bowel syndrome can include:

  • Abdominal pain
  • Anorexia
  • Bloating
  • Constipation
  • Diarrhea
  • Flatulence
  • Food intolerances
  • Nausea
  • Headaches
  • Stomach Cramping
  • Vomiting
  • Excess mucus

Because irritable bowel syndrome can lead to vitamin and mineral deficiencies, many other health problems can accumulate along side this disorder, such as candidiasis, colon cancer, diabetes, gallbladder disease, malabsorbtion diseases, ulcers, parasitic infections, arthritis, pancrease disorders, fibromyalgia, mental disorders and more.

However, don't dispair. I myself use to suffer with irritable bowel, but by taking proactive steps, I was able to overcome this disorder.

Return from Irritable Bowel Syndrome Natural Treatment to the
Natural Health Girl Home Page


Source: www.natural-health-girl.com

Pharmacists Reveal Top Over-The-Counter Product Recommendations

Pharmacists Reveal Top Over-The-Counter Product Recommendations

WASHINGTON, April 23, 2013 /PRNewswire-USNewswire/ -- The American Pharmacists Association (APhA) and Pharmacy Today recently published the results of the 2012 Pharmacy Today Over-the-Counter Product Survey. The survey reveals the over-the-counter (OTC) products pharmacists are recommending most often to their patients. Because there are over 300,000 marketed OTC drug products, it is critical that patients consult their pharmacist to maximize the benefits from these medications and minimize the potential for harmful drug interaction and/or side effects.

Recipients of the 2012 survey were asked to write in approximately how many times per week they had recommended each OTC product. A series of 77 product categories were divided into three groups of questions, each of which was sent to one-third of participants. The survey was conducted in September and October 2012 and published as a supplement to the March 2013 edition of Pharmacy Today. It was completed by over 1,000 practicing community pharmacists who are recipients of Pharmacy Today.

The March 2013 Pharmacy Today OTC Supplement provides the results from the 2012 OTC Survey and a selection of articles and editorial on recent OTC product studies and data about the safe-use of these medications. This information helps pharmacists recommend the best OTC products to optimize patient health outcomes. The recent supplement contained articles on emerging data on the benefits of aspirin therapy; the public health benefits and appropriate use guidelines for at-home HIV tests; the potential of adverse effects from OTC eye drop and nasal spray usage in children; and information about fruit juice interactions with OTC and prescription medications.

Pharmacists work with doctors and other health care providers to optimize care, improve medication use and to prevent disease. To achieve the best outcomes for their condition, patients should maintain regular visits with all of their health care providers. APhA encourages patients to fill all their prescriptions with one pharmacy, get to know their pharmacist on a first name basis, discuss their medications with their pharmacist, carry an up-to-date medication and vaccination list and share all medical information with each of their health care providers.

Optimizing Your Pharmacist's Over-The-Counter Medication Suggestions:

  • Discuss the symptoms you are trying to treat, and the duration of those symptoms, with your pharmacist.
  • Provide the age and weight of the patient to your pharmacist. This is especially important with children's products or if you are caring for an elderly family member, as formulations may differ depending on weight.
  • Read product labeling, take the medication exactly as directed, learn of possible side effects, and ask your pharmacist what should be avoided while taking the medication.
  • Watch for duplicate ingredients. If you are taking or giving more than one OTC medication check the active ingredient(s) used in each medication to make sure you are not using more than one product with the same active ingredient.
  • Do not use a kitchen spoon to measure liquid medications. Obtain appropriate medication administration aids (i.e. droppers, syringes, spoons, etc.) and ask the pharmacist how to use them properly.
  • Do not give medications in the dark. Turn on the lights if your child or family member needs medication at night. Do not give medication to anyone who is not fully awake.
  • Follow good health practices to prevent the spread of contagious illnesses. Cover the mouth and nose during a cough or sneeze, avoid touching the eyes, nose or mouth and wash the hands or use alcohol-based hand sanitizer frequently.
  • Remember, most OTC medications are for temporary relief of minor symptoms. Contact your pharmacist or health care provider if your condition persists or gets worse.

The Pharmacy Today OTC Product Survey and OTC Supplement is available at http://www.pharmacist.com/pharmacy-today-otc-supplement-march-2013

** Being a #1 recommended product in the Pharmacy Today OTC Product Survey does not indicate Pharmacy Today or APhA endorsement of any product or service.

About the American Pharmacists Association
The American Pharmacists Association, founded in 1852 as the American Pharmaceutical Association, is a 501 (c)(6) organization, representing more than 62,000 practicing pharmacists, pharmaceutical scientists, student pharmacists, pharmacy technicians and others interested in advancing the profession. APhA, dedicated to helping all pharmacists improve medication use and advance patient care, is the first-established and largest association of pharmacists in the United States. For more information, please visit www.pharmacist.com.

About Pharmacy Today
Pharmacy Today is the monthly medication therapy management (MTM) magazine of the American Pharmacists Association, offering readers profiles of practices that employ unique MTM techniques to effectively serve their patients. Readers can use these profiles as models to develop and improve their own MTM practice, increase patient adherence, and build patient loyalty. For more information, please visit www.pharmacytoday.org.

SOURCE American Pharmacists Association

RELATED LINKS
http://www.pharmacist.com


Source: www.prnewswire.com

Monday, April 22, 2013

Why are “feminist” and “animal rights activist” dirty words?

Why are “feminist” and “animal rights activist” dirty words?
How many of you would call yourself a ‘feminist’? Have you ever heard a man label himself as one? It’s an interesting question, don’t you think? I had a discussion about feminism with a young guy at my work recently, about how he thought most people were for female equality, but wouldn’t use the word as an adjective to describe anyone he knew.
women at work

Feminists at work! © Lindsay O’Donnell

How many of you would call yourself a ‘feminist’? Have you ever heard a man label himself as one? It’s an interesting question, don’t you think?

I had a discussion about feminism with a young guy at my work recently, about how he thought most people were for female equality, but wouldn’t use the word as an adjective to describe anyone he knew. In his eyes, it has become a word that represents an ‘extremist’, someone who burns their bra and complains about every menial thing because it demeans women. Basically, he said, being ‘a feminist’ wasn’t a compliment or something you’d want on your Linkedin page.

The conversation has stayed with me ever since because I think his opinion represents the majority, and sadly it’s made me live up to the cliché by pissing me off.

The more I think about the term ‘feminist’ and the feminist movement, the more I think that we’ve regressed. Ladies, what the hell has happened?

The dictionary defines feminism ‘as the doctrine advocating social, political, and all other rights of women equal to those of men.’ So how is it possible that anyone of any gender would be embarrassed to label themselves as one?

Here is my humble and extremely simplistic opinion of how we got to where we are today from the roaring ‘60s of bra burning:

After the passion of that decade subsided and some real headway for women was achieved, opponents used a tried and true tactic: brand them as extremists. And I think it’s working. How many have an image of feminism or know someone that associates the term with ‘crazy’, ‘irrational’, or ranting and raving about female inequality. Nobody wants to date, be friends with, or hire someone like that. Right?

It’s a fine line we women have to walk. Acceptance is a part of being happy, but how do we stay firm on equality while being accepted in the mainstream?

Any animal or environmental activist will tell you that they constantly fight the same battle. What image comes to mind when the word “animal rights activist” is used? For many it’s an extremist. But arguably ANYONE who cares about animals, and fights IN ANY WAY for their well being – and that may be by volunteering at their local animal rights shelter – is an animal rights activist. The diversion tactic, whether we’re talking about animal rights activists or feminists, is so effective because the original message, objective, or argument can be swallowed, or dismissed, by this unfair stereotype.

Sadly I think as women we’ve mistaken empowerment with sexual objectification and sexual empowerment with power, as eloquently discussed by Dr. Heldman in this TED Talk.

I think we’ve made other mistakes as well – for example, by owning and using words like ‘bitch’, ‘slut’, or even ‘ho’ we’ve only made feminine slander commonplace and acceptable. We don’t really use the term ‘that’s gay’ anymore because we’ve realized that associating it with negative connotations is destructive and harmful to gay rights and equality. Although associating female adjectives with weakness or superfluous doesn’t seem to resonate as easily, it is just as harmful and counterproductive to women’s rights.

It’s not completely our own doing; we’re working against carefully crafted media messaging and constant reinforcement from society that this behavior is acceptable, celebrated, and normal.

Luckily, feminism is not dead. In fact my personal heroes like Tina Fey, Hilary Clinton, Amy Poehler, Ellen DeGeneres, and the writers at Jezebel, continue to make astute observations about our behaviors and publicly question gender roles in our society without being the stereotypical woman ranting and raving with a flaming piece of underwear. I think women and men continue to make amazing progress in social expectations, labels, and gender stereotypes.

But I also think that it’s critical that we take back the word ‘feminist’; otherwise it will be used against future progress. Therefore, I would like to conclude by saying: my name is Lindsay and I am a feminist!


Source: feedproxy.google.com

CQDM and the Massachusetts Life Sciences Center announce a new international partnership program

CQDM and the Massachusetts Life Sciences Center announce a new international partnership program

CHICAGO, IL, April 22, 2013 /PRNewswire/ - CQDM is joining the Massachusetts Life Sciences Center (MLSC) in a new initiative to create an International Collaborative Industry Program (ICIP). This initiative is a concrete action to promote and facilitate the establishment of partnerships between Massachusetts and Quebec-based life sciences companies for research and development of new products and processes intended for commercialization.

Announced at the BIO International Convention 2013, with the presence of the Minister Marceau, this international collaboration will build on existing strengths in Massachusetts and in Québec to increase innovation, productivity, investment and job creation in these two jurisdictions.

This program is dedicated to late-stage R&D companies from different sectors such as biotechnology, pharmaceuticals, medical devices, diagnostics and bioinformatics to submit project applications. For this ICIP competition, the winning Quebec companies will be eligible for funding up to $2 million. CQDM funds 50% of the Quebec portion of the project to a maximum of $ 500,000; companies will match the funding that CQDM provides. The MLSC will provide each winning Massachusetts company with up to $500,000 in matching funding. Detailed information on the CQDM / MLSC funding program is available on CQDM's website.

"No one country or region can solve the challenge of developing the next generation of  drugs and medical devices on its own," said Susan Windham-Bannister , Ph.D., President & CEO of the MLSC, ICIP sponsor and the agency charged with implementing Massachusetts Governor Deval Patrick's 10-year, $1 billion Life Sciences Initiative. "The breakthroughs of tomorrow will only be possible through collaboration like that which we are fostering between Massachusetts and Quebec."

"Research and innovation play a central role in the growth of the life sciences sector in Quebec," said Quebec's Minister of Finance and Economy, Nicolas Marceau . "Our participation in the International Collaborative Industry Program is thus strategic for Quebec. In fact, project funding through the Quebec Consortium for Drug Discovery (CQDM) will strengthen the innovative base of our companies and consolidate the strong links we share with Massachusetts, particularly in link with the joint declaration signed in 2009 with the Massachusetts Office of International Trade and Investment. Quebec's participation in this program is thus in line with the actions that our government is putting in place to adapt to the new business model of the world industry that suppose partnerships and collaborations in the field of research and innovation."

"This unique partnership between Quebec and Massachusetts capitalizes on the synergies between the two regions in Life Sciences and paves the way for new investment opportunities and collaborations," said Diane Gosselin , President Executive Director of CQDM. "This new funding program will enable industry research partnership in Life Sciences, in continuity with CQDM's mission which, through innovative actions, wants to accelerate the process of drug discovery."

About CQDM
CQDM is a meeting ground for all stakeholders in biopharmaceutical research. Its principal mission is to fund research projects carried out in partnership between the academic and private sectors. An innovative Canadian initiative, CQDM has two major goals: to accelerate the drug discovery process and to develop safer and more effective drugs. CQDM is funded through contributions from Pfizer Canada, AstraZeneca, Merck, Boehringer Ingelheim (Canada) Ltd., GlaxoSmithKline Inc., Eli Lilly Canada Inc., Novartis Pharmaceuticals Canada Inc., the Business-Led Networks of Centres of Excellence (BL-NCE) and the Ministère de l'Enseignement supérieur, de la Recherche, de la Science et de la Technologie du Québec. For more information:
www.cqdm.org.

About the Massachusetts Life Sciences Center
The Massachusetts Life Sciences Center (MLSC) is a quasi-public agency of the Commonwealth of Massachusetts tasked with implementing the Massachusetts Life Sciences Act, a 10-year, $1-billion initiative that was signed into law in June of 2008. The MLSC's mission is to create jobs in the life sciences and support vital scientific research that will improve the human condition. This work includes making financial investments in public and private institutions that are advancing life sciences research, development and commercialization as well as building ties among sectors of the Massachusetts life sciences community. For more information, visit www.masslifesciences.com.

About the International Collaborative Industry Program (ICIP)
The MLSC's International Collaborative Industry Program (ICIP) seeks to promote collaboration and idea exchange between life sciences companies around the world, as well as to stimulate the development of new products or processes intended for commercialization. ICIP accepts project proposals rooted in the life sciences: Biotechnology, pharmaceuticals, medical devices, diagnostics and bioinformatics. Projects sponsored together by a Massachusetts life sciences company and a company from one of the participating international partner regions are eligible to apply for joint funding from the MLSC and the respective international partner agency. For more information about ICIP, visit www.masslifesciences.com or email icip@masslifesciences.com

SOURCE CQDM


Source: www.prnewswire.com